Clinical Trials Directory

Trials / Unknown

UnknownNCT00409227

Does Treatment With Alfuzosin Increase Success Rates of (SWL) Shock Wave Lithotripsy

Prospective Randomized Placebo Controlled Blinded Study to Evaluate the Efficacy of Alfuzosin (Alpha Blocker) on the Success Rates Following SWL.

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Assaf-Harofeh Medical Center · Other Government
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

In latest literature more evidence is available about the positive effect of alpha blocker on stone expulsion from the ureter. Patients benefit from less pain and shortening time to stone expulsion. Our study is design to evaluate whether alfuzosin improves the stone free out come following SWL.

Detailed description

All patients undergoing SWL are included in study. Exclusion criteria: Patient with radio-lucent stone, patients treated with calcium channel blockers, alpha blockers, steroids, patients with contraindication to alpha blocker treatment, postural hypotension patents with abnormal liver function tests. Patient will be recruited to the study prospectively. Following signature on inform consent patients will be randomized into 2 groups. One group will be treated with alfuzosin 10mg a day and the control group with placebo. Treatment will be initiated following the lithotripsy treatment. Parameters for investigation includes: demographic and personal data, stone size and location (obtained by CT or KUB), pain control medication and visual analogue scale assessment of pain, side effects, clinical squeals, stone free out come. Follow up evaluation will be at 1 week, 1 month, and 3 months post treatment. Success will be defined following CT evaluation at 3 months. Treatment ends at stone free achievement or at 3 months. Endpoints:Stone free rate, time to stone free, side effect.

Conditions

Interventions

TypeNameDescription
DRUGAlpha blocker-alfuzosinP.O. alfuzosin 10 mg once a day
DRUGplaceboplacebo once a day for 3 months or stone free

Timeline

Start date
2006-12-01
Primary completion
2009-07-01
First posted
2006-12-08
Last updated
2008-06-18

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00409227. Inclusion in this directory is not an endorsement.